First Venture Technologies Corp.
TSX VENTURE : FEB

First Venture Technologies Corp.

March 27, 2007 09:01 ET

First Venture Plans Financing

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - March 27, 2007) - First Venture Technologies Corp. (TSX VENTURE:FEB) reports that it plans to undertake a private placement to raise $3.04 million through the issuance of 3.2 million units. Each unit will consist of one common share and one-half of a share purchase warrant, with each whole warrant exercisable, for a period of 18 months from closing, into one common share at a price of $1.25. The private placement is subject to receipt of TSX Venture Exchange acceptance.

ON BEHALF OF THE BOARD

Howard Louie, President & Chief Executive Officer

ABOUT FIRST VENTURE TECHNOLOGIES

First Venture is a biotechnology company that develops and commercializes advanced yeast products. The company is commercializing a platform yeast technology that substantially reduces the formation of a known carcinogen, ethyl carbamate (or urethane) from food products and alcoholic beverages. First Venture has licensed the exclusive worldwide rights to the technology from The University of British Columbia, and is developing the technology in partnership with the University's world-renowned Wine Research Centre.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information